 A total of 353 men and women will be recruited for the three-year trial. Participants will be randomized into a treatment group to receive either vitamin E DL-alpha-tocopherol 400 IUday or a placebo. The ultrasound measurement of CCA IMT will be repeated every six months for two years. 